Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?

about

Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.

P2860

Q33788049-C248D19D-A362-4BA2-9638-C9A3D08E2A94

P2860

Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?

Item

http://www.wikidata.org/entity/Q38366141

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Low immunogenicity in non-smal ...... novel treatments have a role?

@en

type

Item

label

Low immunogenicity in non-smal ...... novel treatments have a role?

@en

prefLabel

Low immunogenicity in non-smal ...... novel treatments have a role?

@en

P1476

Low immunogenicity in non-smal ...... novel treatments have a role?

@en

P2093

A B Ariffin

http://www.w3.org/2001/XMLSchema#string

B Bird

http://www.w3.org/2001/XMLSchema#string

D Soden

http://www.w3.org/2001/XMLSchema#string

J Hinchion

http://www.w3.org/2001/XMLSchema#string

P Forde

http://www.w3.org/2001/XMLSchema#string

R E Gardiner

http://www.w3.org/2001/XMLSchema#string

S Jahangeer

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

A minimal model for the self-nonself discrimination: a return to the basics

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Improved endpoints for cancer immunotherapy trials

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Electrochemotherapy: aspects of preclinical development and early clinical experience

P2888

s10555-015-9550-8

P304

129-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-015-9550-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046796508

http://www.w3.org/2001/XMLSchema#string

P698

25726003

http://www.w3.org/2001/XMLSchema#string

Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?

about

P2860

P2860

Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698